Relapse management in multiple sclerosis

The Neurologist
Ben W Thrower

Abstract

Relapses, exacerbations, and attacks are synonymous for new or worsened neurologic symptoms that are the hallmark of relapsing-remitting multiple sclerosis. Management of relapses is not always straightforward. The clinician must distinguish between true relapses, symptom fluctuation, and pseudo-relapses. Risks and benefits of treating a relapse must be considered. Once the decision to treat is made, most clinicians would pursue a course of corticosteroids. Consensus may end there, as there is no clear-cut "best" route of administration or dosing schedule. The patient presenting with their first relapse or clinically isolated syndrome may be at risk for the development of multiple sclerosis. Clinical presentation, CSF findings, and MRI may all give clues as to the risk for future demyelinating events.

References

Jun 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·D H MillerW I McDonald
Jun 1, 1983·Italian Journal of Neurological Sciences·G AbbruzzeseC Loeb
Nov 1, 1994·Archives of Neurology·A D SadovnickD W Paty
Jan 1, 1994·Annals of Neurology·B G Weinshenker
Nov 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·S M AlamP K Newman
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
Jul 25, 2000·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F SellebjergJ L Frederiksen
Feb 15, 2001·The New England Journal of Medicine·C ConfavreuxUNKNOWN Vaccines in Multiple Sclerosis Study Group
Apr 26, 2001·Multiple Sclerosis : Clinical and Laboratory Research·N D RichertJ A Frank
Mar 29, 2002·Annals of Neurology·Roy W BeckAlfred W Sandrock
Feb 14, 2003·Archives of Ophthalmology·Adam P Beck, Robert S Feder
Sep 4, 2003·BMC Health Services Research·Judith A O'BrienJaime Caro
Sep 23, 2003·BMJ : British Medical Journal·D BuljevacR Q Hintzen
May 8, 2004·Brain : a Journal of Neurology·Sandra VukusicUNKNOWN Pregnancy In Multiple Sclerosis Group
Jun 8, 2004·Acta Neurologica Scandinavica·G SalemiG Savettieri
Sep 11, 2004·Western Journal of Nursing Research·Elsie E Gulick, Shanda Johnson
Dec 15, 2004·Neurology·P Soelberg SorensenUNKNOWN TARIMS Study Group
Jul 27, 2005·Multiple Sclerosis : Clinical and Laboratory Research·Thomas F ScottShalu Singh
Jul 28, 2006·Neurology·Jorge CorrealeWendy Gilmore
Mar 6, 2007·Journal of the Neurological Sciences·Fred D Lublin

❮ Previous
Next ❯

Citations

Oct 1, 2012·International Journal of MS Care·Amy Perrin RossColleen J Harris
Oct 5, 2010·Journal of Medical Economics·Benjamin J ChastekMaria V Lopez-Bresnahan
Jan 6, 2012·The Patient·Merrikay Oleen-BurkeyKenneth P Johnson
Aug 31, 2016·Pharmaceutical Development and Technology·Nargess GandomiRassoul Dinarvand
Aug 29, 2013·The Neurohospitalist·Jacqueline F Marcus, Emmanuelle L Waubant
Oct 21, 2016·AJNR. American Journal of Neuroradiology·J PakpoorD M Yousem
Mar 5, 2013·The Nurse Practitioner·Heidi Wynn Maloni
Jun 6, 2018·Neurodegenerative Disease Management·Christen F Kutz, Amy L Dix
Jan 22, 2013·Clinical Neuropharmacology·Vahid ShaygannejadFarzad Fatehi
Mar 22, 2015·Current Treatment Options in Neurology·Carolyn Bevan, Jeffrey M Gelfand
Feb 9, 2011·Clinical Neuropharmacology·Irina ElovaaraBirgit Reipert
Nov 17, 2020·Frontiers in Immunology·Tatiana KoudriavtsevaMatilde Inglese
May 31, 2018·Neurología : publicación oficial de la Sociedad Española de Neurología·L A Rodríguez de AntonioC Oreja Guevara
Jul 10, 2021·Neurología·L A Rodríguez de AntonioC Oreja Guevara
Jan 20, 2012·Journal of Proteome Research·Radka SaldovaPauline M Rudd

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.